Sergey Ivanov

Dr. Sergey Ivanov

orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 June 2013 in Bioinformatics
Verified
Journal Article
Open access
PDF file
ALAlexey Lagunin
Alexey Lagunin
SISergey Ivanov
Sergey Ivanov
ARAnastasiya Rudik
Anastasiya Rudik
DFDmitry Filimonov
Dmitry Filimonov
Vladimir Vassilievich PoroikovVladimir Vassilievich Poroikov
Vladimir Vassilievich Poroikov
Summary: Experimentally found gene expression profiles are used to solve different problems in pharmaceutical studies, such as drug repositioning, resistance, toxicity and drug–drug interactions. A special web service, DIGEP-Pred, for prediction of drug-induced changes of gene expression profiles based on structural formulae of chemicals has been developed. Structure–activity relationships for prediction of drug-induced gene expression profiles were determined by Prediction of Activity Spectra for Substances (PASS) software. Comparative Toxicogenomics Database with data on the known drug-induced gene expression profiles of chemicals was used to create mRNA- and protein-based training sets. An average prediction accuracy for the training sets (ROC AUC) calculated by leave-one-out cross-validation on the basis of mRNA data (1385 compounds, 952 genes, 500 up- and 475 down-regulations) and protein data (1451 compounds, 139 genes, 93 up- and 55 down-regulations) exceeded 0.85. Availability: Freely available on the web at http://www.way2drug.com/GE. Contact:alexey.lagunin@ibmc.msk.ru Supplementary information: Supplementary data are available at Bioinformatics online.

1 October 2017 in Russian Chemical Bulletin
Verified
Journal Article
Closed access
PDF file
DDDmitry Druzhilovskiy
Dmitry Druzhilovskiy
ARAnastasiya Rudik
Anastasiya Rudik
DFDmitry Filimonov
Dmitry Filimonov
TGT. A. Gloriozova
T. A. Gloriozova
ALAlexey Lagunin
Alexey Lagunin
VPV. V. Poroikov
V. V. Poroikov

22 July 2014 in Natural Product Reports
Verified
Journal Article
Closed access
PDF file
ALAlexey Lagunin
Alexey Lagunin
RGRajesh K. Goel
Rajesh K. Goel
DGDinesh Y GAWANDE
Dinesh Y GAWANDE
PPPriynka Pahwa
Priynka Pahwa
TGTatyana A. Gloriozova
Tatyana A. Gloriozova
Vladimir Vassilievich PoroikovVladimir Vassilievich Poroikov
Vladimir Vassilievich Poroikov
Covering: up to 2014 In silico approaches have been widely recognised to be useful for drug discovery. Here, we consider the significance of available databases of medicinal plants and chemo- and bioinformatics tools for in silico drug discovery beyond the traditional use of folk medicines. This review contains a practical example of the application of combined chemo- and bioinformatics methods to study pleiotropic therapeutic effects (known and novel) of 50 medicinal plants from Traditional Indian Medicine.

22 December 2017 in Journal of Chemical Information and Modeling
Verified
Journal Article
Closed access
SISergey Ivanov
Sergey Ivanov
ALAlexey Lagunin
Alexey Lagunin
ARAnastasiya Rudik
Anastasiya Rudik
DFDmitry Filimonov
Dmitry Filimonov
Vladimir Vassilievich PoroikovVladimir Vassilievich Poroikov
Vladimir Vassilievich Poroikov

Verified
Journal Article
Open access
PDF file
ALAlexey Lagunin
Alexey Lagunin
ARAnastasiya Rudik
Anastasiya Rudik
PPPavel Viktorovich Pogodin
Pavel Viktorovich Pogodin
PSPolina Savosina
Polina Savosina
Olga TarasovaOlga Tarasova
Olga Tarasova
Vladimir Vassilievich PoroikovVladimir Vassilievich Poroikov
Vladimir Vassilievich Poroikov
In vitro cell-line cytotoxicity is widely used in the experimental studies of potential antineoplastic agents and evaluation of safety in drug discovery. In silico estimation of cytotoxicity against hundreds of tumor cell lines and dozens of normal cell lines considerably reduces the time and costs of drug development and the assessment of new pharmaceutical agent perspectives. In 2018, we developed the first freely available web application (CLC-Pred) for the qualitative prediction of cytotoxicity against 278 tumor and 27 normal cell lines based on structural formulas of 59,882 compounds. Here, we present a new version of this web application: CLC-Pred 2.0. It also employs the PASS (Prediction of Activity Spectra for Substance) approach based on substructural atom centric MNA descriptors and a Bayesian algorithm. CLC-Pred 2.0 provides three types of qualitative prediction: (1) cytotoxicity against 391 tumor and 47 normal human cell lines based on ChEMBL and PubChem data (128,545 structures) with a mean accuracy of prediction (AUC), calculated by the leave-one-out (LOO CV) and the 20-fold cross-validation (20F CV) procedures, of 0.925 and 0.923, respectively; (2) cytotoxicity against an NCI60 tumor cell-line panel based on the Developmental Therapeutics Program’s NCI60 data (22,726 structures) with different thresholds of IG50 data (100, 10 and 1 nM) and a mean accuracy of prediction from 0.870 to 0.945 (LOO CV) and from 0.869 to 0.942 (20F CV), respectively; (3) 2170 molecular mechanisms of actions based on ChEMBL and PubChem data (656,011 structures) with a mean accuracy of prediction 0.979 (LOO CV) and 0.978 (20F CV). Therefore, CLC-Pred 2.0 is a significant extension of the capabilities of the initial web application.

1 January 2016 in Drug Discovery Today
Verified
Journal Article
Closed access
SISergey Ivanov
Sergey Ivanov
ALAlexey Lagunin
Alexey Lagunin
Vladimir Vassilievich PoroikovVladimir Vassilievich Poroikov
Vladimir Vassilievich Poroikov